References
- de Weers M, Tai YT, van der Veer MS, et al. Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. J Immunol 2011;186:1840–8.
- Chapuy CI, Nicholson RT, Aguad MD, et al. Resolving the daratumumab interference with blood compatibility testing. Transfusion 2015;55:1545–54.
- Plesner T, Lokhorst H, Gimsing P, et al. Daratumumab, a CD38 monoclonal antibody in patients with multiple myeloma: data from a dose-escalation phase I/II study. ASH Annual Meeting Abstracts 2012;120:73.
- Fung MK, Grossman BJ, Hillyer CD, Westhoff CM, Eds. Technical manual. 18th ed. Bethesda, MD: AABB, 2014.
- Harmening D. Modern blood banking and transfusion practices. 5th ed. Baltimore, MD: FA Davis, 2005.
- Reid ME, Lomas-Francis C, Olsson ML. The blood group antigen facts book. 3rd ed. Waltham, MA: Academic Press, 2012.